Slow inhibition of almond beta-glucosidase by azasugars: determination of activation energies for slow binding.
The thermodynamic and activation energies of the slow inhibition of almond beta-glucosidase with a series of azasugars were determined. The inhibitors studied were isofagomine ((3R,4R,5R)-3,4-dihydroxy-5-hydroxymethylpiperidine, 1), isogalactofagomine ((3R,4S,5R)-3,4-dihydroxy-5-hydroxymethylpiperidine, 2), (-)-1-azafagomine ((3R,4R,5R)-4,5-dihydroxy-3-hydroxymethylhexahydropyridazine, 3), 3-amino-3-deoxy-1-azafagomine (4) and 1-deoxynojirimycin (5). It was found that the binding of 1 to the enzyme has an activation enthalpy of 56.1 kJ/mol and an activation entropy of 25.8 J/molK. The dissociation of the enzyme-1 complex had an activation enthalpy of -2.5 kJ/mol and an activation entropy of -297 J/molK. It is suggested that the activation enthalpy of association is due to the breaking of bonds to water, while the large negative activation entropy of dissociation is due at least in part to the resolvation of the enzyme with water molecules. For the association of 1 DeltaH(0) is 58.6 kJ/mol and DeltaS(0) is 323.8 J/molK. Inhibitor 3 has an activation enthalpy of 39.3 kJ/mol and an activation entropy of -17.9 J/molK for binding to the enzyme, and an activation enthalpy of 40.8 kJ/mol and an activation entropy of -141.0 J/molK for dissociation of the enzyme-inhibitor complex. For the association of 3 DeltaH(0) is -1.5 kJ/mol and DeltaS(0) is 123.1 J/molK. Inhibitor 5 is not a slow inhibitor, but its DeltaH(0) and DeltaS(0) of association are -30 kJ/mol and -13.1 J/molK. The large difference in DeltaS(0) of association of the different inhibitors suggests that the anomeric nitrogen atom of inhibitors 1-4 is involved in an interaction that results in a large entropy increase.
Bülow
A
A
Department of Chemistry, Aarhus University, DK-8000, Aarhus, Denmark.
Plesner
I W
IW
Bols
M
M
D017485:1-Deoxynojirimycin / Q000494:pharmacology; D002241:Carbohydrates / Q000494:pharmacology*; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D005690:Galactose / Q000031:analogs & derivatives / Q000494:pharmacology; D050112:Imino Pyranoses; D007212:Indolizines / Q000494:pharmacology; D007700:Kinetics; D009754:Nuts / Q000201:enzymology; D010880:Piperidines / Q000494:pharmacology; D010940:Plant Proteins / Q000037:antagonists & inhibitors*; D011485:Protein Binding; D013816:Thermodynamics; D001617:beta-Glucosidase / Q000037:antagonists & inhibitors*
C414749:1-azafagomine; C427223:3-amino-3-deoxy-1-azafagomine; D002241:Carbohydrates; D004791:Enzyme Inhibitors; D050112:Imino Pyranoses; D007212:Indolizines; D010880:Piperidines; D010940:Plant Proteins; C098432:isofagomine; C416964:isogalactofagomine; D017485:1-Deoxynojirimycin; D001617:beta-Glucosidase; D005690:Galactose